CAS 118801-67-5

1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one, 5,6,7,8-tetrahydro-

Description:

1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one, 5,6,7,8-tetrahydro- is a heterocyclic compound characterized by its fused triazole and pyridine rings, which contribute to its unique chemical properties. This compound typically exhibits a molecular structure that includes nitrogen atoms in the triazole ring, enhancing its potential for various biological activities. The presence of the tetrahydro moiety indicates that it has a saturated cyclic structure, which can influence its reactivity and solubility. It is often studied for its pharmacological properties, including potential applications in medicinal chemistry, where it may exhibit antimicrobial, anti-inflammatory, or anticancer activities. The compound's CAS number, 118801-67-5, allows for its identification in chemical databases, facilitating research and development. Its synthesis and characterization are of interest in the field of organic chemistry, particularly in the design of new compounds with specific biological functions. Overall, this substance represents a significant area of study due to its structural complexity and potential therapeutic applications.

Formula: C₆H₉N₃O

5,6,7,8-Tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one

CAS: 118801-67-5

Purity: 95%

Molecular weight: 139.1580048

Ref: 10-F619466

2H,3H,5H,6H,7H,8H-[1,2,4]Triazolo[4,3-a]pyridin-3-one

CAS: 118801-67-5

The invention relates to a combination of two or more triazolopyridines, wherein the individual compounds are selected from the group consisting of 2H,3H,5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridin-3-one and pharmaceutically acceptable salts thereof. This invention also relates to a pharmaceutical composition comprising the combination of two or more triazolopyridines as well as a pharmaceutically acceptable carrier. This invention also relates to methods for treating lung inflammation by administering a therapeutically effective amount of the combination of two or more triazolopyridines. This invention also relates to methods for prophylaxis against lung inflammation by administering an effective amount of the combination of two or more triazolopyridines.

Formula: C₆H₉N₃O

Purity: Min. 95%

Molecular weight: 139.16 g/mol

Ref: 3D-TEA80167